Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside
Mumbai: In relief to Ajanta Pharma Ltd, the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Mumbai has set aside a Rs 2 lakh penalty imposed on the company in connection with the alleged misdeclaration of exported erectile dysfunction drugs including Kamagra Oral Jelly, Super Kamagra Tablets, and Kamagra Gold Tablets.
The matter relates to 43 consignments exported between September 11, 2018, and March 10, 2021, which included Kamagra Oral Jelly, Super Kamagra Tablets, and Kamagra Gold Tablets. Although the shipping bills, invoices, and packing lists carried correct descriptions of the goods, the corresponding airway bills were marked as “medical apparatus.” The customs department treated this as misdeclaration under Para 2.06(a) of Chapter 2 of the Foreign Trade Policy 2015-20 and DGFT notification dated 12.03.2015, imposing a penalty under Section 117 of the Customs Act.
Ajanta Pharma challenged this decision before the Tribunal. During the hearing, Dr Suvendu Kumar Pati, Member (Judicial), observed:
“Section 117 is restricted to imposition of penalties for contravention of provisions of Customs Act only or for its abetment... No such violation is noticeable here.”
The Tribunal noted that the Customs authorities themselves admitted that the shipping documents bore accurate product descriptions, and only the airway bills – a document handled by freight forwarding agents – carried the alternate terminology. The show cause notice and the Order-in-Original were based on provisions from the Foreign Trade Policy, but no direct violation of the Customs Act was alleged or proven.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.